Lung Cancers Today

?? It's been an exciting first day of the European Lung Cancer Congress with the much-anticipated presentation of final OS results from MARIPOSA! ? Don't miss this insightful interview with Nicolas Girard, MD, PhD, of Institut Curie, who weighs in on the data and implications. ?? Watch: https://lnkd.in/gdPFeBkx #NSCLC #lcsm #ELCC25 #EGFR

?? Today's the day! ? The European Lung Cancer Congress kicks off in Paris with the opening session and Heine H. Hansen Award at 1:50 p.m. CET! ?? Follow us and stay tuned for our #ELCC25 coverage here: https://lnkd.in/gcZYkdhq #ELCC2025 #lcsm #LungCancer

?? We're counting down until the European Lung Cancer Congress kicks off in Paris tomorrow! ? In the meantime, don't miss this interview with Dr. Stephen Liu of Georgetown University Lombardi Comprehensive Cancer Center, who discusses key highlights of the upcoming meeting. ?? Watch: https://lnkd.in/geiKMn2D #lcsm #LungCancer #ELCC2025 #ELCC25 #NSCLC #SCLC

?? What are the real-world outcomes with lobectomy versus sublobar resection in patients with stage 1A NSCLC? ?? Don't miss this interview with Christopher Seder, MD, of Rush University Medical Center, who shares key insights from a study that he presented at the 61st Annual Meeting of The Society of Thoracic Surgeons. ?? Watch now: https://lnkd.in/g3GZP_xN

?? ICYMI: Amivantamab plus lazertinib showed anti-tumor activity in a group of patients with limited treatment options for NSCLC, according to CHRYSALIS-2 data published by Dr. Benjamin Besse of Gustave Roussy and colleagues. ?? Read more: https://buff.ly/3W7rXcb #NSCLC #lcsm #LungCancer

?? Perioperative pembrolizumab showed a “promising” major pathologic response rate and survival outcomes in patients with early-stage non–small NSCLC, according to a recent study by Cameron Wood, MD,?of Bon Secours, and colleagues that suggests there may be a biomarker of major pathologic response in this setting. ?? Learn more: https://lnkd.in/gmjFne3v

??? Can hyperthermic intrathoracic chemotherapy remodel the pleural mesothelioma tumor immune microenvironment? ?? A new study by a team from CHUV |?Lausanne university hospital provided insights. ?? Learn more: https://lnkd.in/gG5CGykF #lcsm #LungCancer #Mesothelioma

??? What's the best smoking cessation strategy for those who are undergoing lung cancer screening? ?? A team from MD Anderson Cancer Center conducted a randomized clinical trial to evaluate 3 smoking cessation strategies in a lung cancer screening setting. ?? Read more: https://lnkd.in/gHeTtRTJ #lcsm

?? Baseline physical symptom burden may be prognostic of survival among patients with advanced malignant pleural mesothelioma, according to a recent study by Dr. Abhenil Mittal and colleagues. ?? Learn more: https://lnkd.in/g99jDi_3 #mesothelioma #lcsm

?? Trastuzumab rezetecan showed “clinically meaningful activity” in patients who received previous treatment for?HER2-mutated NSCLC, according to recent findings from the phase 2 HORIZON-Lung trial ?? Learn more: https://lnkd.in/gDEgmbjn #lcsm #NSCLC #LungCancer